A new clinical trial revealed fecal microbiota transplantation (FMT) as a potential new treatment for Parkinson’s disease (PD), showing significant improvement in motor symptoms. The study explores the connection between the gut microbiome and Parkinson's, finding that patients with PD often exhibit altered gut bacteria and increased intestinal inflammation.